Cabaletta Bio
(NASDAQ:CABA)
$11.07
0.08[0.73%]
At close: Jun 11
$11.07
0[0.00%]
After Hours: 4:00PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$50.00
Lowest Price Target1
$10.00
Consensus Price Target1
$26.50

Cabaletta Bio Stock (NASDAQ:CABA), Analyst Ratings, Price Targets, Predictions

Cabaletta Bio Inc has a consensus price target of $26.5, established from looking at the 42 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald on May 24, 2024, May 16, 2024, and April 5, 2024. With an average price target of $36.67 between HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 231.23% upside for Cabaletta Bio Inc from these 3 analyst ratings.

Analyst Trend
1
Feb
3
Mar
2
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Cantor Fitzgerald
Citigroup
Wells Fargo
Jefferies

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Cabaletta Bio

Buy NowGet Alert
05/24/2024Buy Now171%HC Wainwright & Co.
Douglas Tsao
 → $30ReiteratesBuy → BuyGet Alert
05/16/2024Buy Now171%HC Wainwright & Co.
Douglas Tsao
 → $30ReiteratesBuy → BuyGet Alert
04/05/2024Buy Now351.67%Cantor Fitzgerald
Joshua Schimmer
 → $50ReiteratesOverweight → OverweightGet Alert
04/04/2024Buy Now171%Citigroup
Samantha Semenkow
$26 → $30MaintainsBuyGet Alert
03/22/2024Buy Now351.67%Cantor Fitzgerald
Joshua Schimmer
 → $50ReiteratesOverweight → OverweightGet Alert
03/22/2024Buy Now216.17%Wells Fargo
Derek Archila
$34 → $35MaintainsOverweightGet Alert
03/22/2024Buy Now171%HC Wainwright & Co.
Douglas Tsao
$25 → $30MaintainsBuyGet Alert
02/05/2024Buy Now225.2%Jefferies
Kelly Shi
 → $36Initiates → BuyGet Alert
11/29/2023Buy Now125.84%Morgan Stanley
Michael Ulz
$28 → $25MaintainsOverweightGet Alert
11/29/2023Buy Now125.84%HC Wainwright & Co.
Douglas Tsao
 → $25ReiteratesBuy → BuyGet Alert
11/15/2023Buy Now351.67%Cantor Fitzgerald
Joshua Schimmer
$40 → $50MaintainsOverweightGet Alert
11/10/2023Buy Now125.84%HC Wainwright & Co.
Douglas Tsao
$17 → $25MaintainsBuyGet Alert
11/08/2023Buy Now152.94%Morgan Stanley
Michael Ulz
$16 → $28MaintainsOverweightGet Alert
10/24/2023Buy Now261.34%Cantor Fitzgerald
Joshua Schimmer
 → $40Initiates → OverweightGet Alert
10/19/2023Buy Now180.04%Stifel
Ben Burnett
 → $31Initiates → BuyGet Alert
10/04/2023Buy Now53.57%HC Wainwright & Co.
Douglas Tsao
 → $17ReiteratesBuy → BuyGet Alert
09/18/2023Buy Now252.3%Wells Fargo
Derek Archila
$14 → $39MaintainsOverweightGet Alert
09/05/2023Buy Now98.74%Citigroup
Samantha Semenkow
 → $22Initiates → BuyGet Alert
08/14/2023Buy Now207.14%Guggenheim
Yatin Suneja
 → $34ReiteratesBuy → BuyGet Alert
08/11/2023Buy Now53.57%HC Wainwright & Co.
Douglas Tsao
$15 → $17MaintainsBuyGet Alert
07/18/2023Buy Now207.14%Guggenheim
Yatin Suneja
 → $34Initiates → BuyGet Alert
05/17/2023Buy Now35.5%HC Wainwright & Co.
Douglas Tsao
 → $15ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now35.5%HC Wainwright & Co.
Douglas Tsao
 → $15ReiteratesBuy → BuyGet Alert
05/03/2023Buy Now35.5%HC Wainwright & Co.
Douglas Tsao
 → $15Reiterates → BuyGet Alert
04/10/2023Buy Now35.5%HC Wainwright & Co.
Douglas Tsao
 → $15Reiterates → BuyGet Alert
04/03/2023Buy Now35.5%HC Wainwright & Co.
Douglas Tsao
 → $15Reiterates → BuyGet Alert
03/22/2023Buy Now8.4%Chardan Capital
Geulah Livshits
 → $12Reiterates → BuyGet Alert
03/17/2023Buy Now-9.67%Mizuho
Uy Ear
 → $10Reiterates → BuyGet Alert
03/17/2023Buy Now35.5%HC Wainwright & Co.
Douglas Tsao
$11 → $15MaintainsBuyGet Alert
02/17/2023Buy Now-0.63%HC Wainwright & Co.
Douglas Tsao
 → $11Reiterates → BuyGet Alert

FAQ

Q

What is the target price for Cabaletta Bio (CABA)?

A

The latest price target for Cabaletta Bio (NASDAQ: CABA) was reported by HC Wainwright & Co. on May 24, 2024. The analyst firm set a price target for $30.00 expecting CABA to rise to within 12 months (a possible 171.00% upside). 21 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cabaletta Bio (CABA)?

A

The latest analyst rating for Cabaletta Bio (NASDAQ: CABA) was provided by HC Wainwright & Co., and Cabaletta Bio reiterated their buy rating.

Q

When was the last upgrade for Cabaletta Bio (CABA)?

A

The last upgrade for Cabaletta Bio Inc happened on January 27, 2023 when Morgan Stanley raised their price target to $16. Morgan Stanley previously had an equal-weight for Cabaletta Bio Inc.

Q

When was the last downgrade for Cabaletta Bio (CABA)?

A

The last downgrade for Cabaletta Bio Inc happened on August 30, 2022 when Morgan Stanley changed their price target from $15 to $3 for Cabaletta Bio Inc.

Q

When is the next analyst rating going to be posted or updated for Cabaletta Bio (CABA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cabaletta Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cabaletta Bio was filed on May 24, 2024 so you should expect the next rating to be made available sometime around May 24, 2025.

Q

Is the Analyst Rating Cabaletta Bio (CABA) correct?

A

While ratings are subjective and will change, the latest Cabaletta Bio (CABA) rating was a reiterated with a price target of $30.00 to $30.00. The current price Cabaletta Bio (CABA) is trading at is $11.07, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch